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Cholera vaccination: How and when to use it
D. Sack
Johns Hopkins Bloomberg School of Public Health,
Baltimore, MD, USA
After nearly three decades of research with killed oral cholera
vaccine (OCV), in 2010 the World Health Organization revised
recommendations regarding the use of OCV to state,1 “Given the
availability of two oral cholera vaccines and data on their efﬁcacy,
ﬁeld effectiveness, feasibility and acceptance in cholera-affected
populations, immunization with these vaccines should be used in
conjunction with other prevention and control strategies in areas
where the disease is endemic and should be considered in areas at
risk for outbreaks.” Then in 2013 an OCV stockpile was developed
(http://www.who.int/cholera/vaccines/ocv stockpile 2013/en/),
and GAVI decided to provide additional funding for OCV.
Clearly OCV is now one of the tools to be used for control-
ling cholera. When OCV is provided to vulnerable people without
safe water who often also lack medical care, OCV becomes a life-
saving vaccine. Still there continues to be uncertainty in knowing
when and where to implement OCV campaigns. Even if funds were
available to pay for the vaccine (3.70 USD/immunized person), the
available supply is limited. Thus, the international community is
now learning how and when to use OCV and how to integrate it
with other cholera control interventions. Some lessons are how-
ever becoming clear. The vaccine is safe and acceptable; it lowers
the risk of cholera by about 65-70%; protection continues for 3 to
5 years; and when coverage is high, it induces herd protection. In
addition, when incidence is high (>1/1000), it is likely to be cost
effective and potentially cost saving.
Currently, the stockpile targets use of the vaccine to emergency
situations, such as unexpected epidemics, where there is hope that
the rapid use of vaccine can abort the outbreak. However, com-
puter models clearly demonstrate that OCV can reduce cholera’s
burden in endemic areaswith predictable cholera seasons. The spe-
ciﬁc strategies for its use, age groups to target, and precisemethods
for OCV campaigns are still being evaluated.
This presentation will discuss the different scenarios when OCV
might be considered and will provide a framework for understand-
ing when and where OCV will be especially beneﬁcial. Additional
guidance for use of OCV is found at www.stopcholera.org and
http://www.who.int/cholera/vaccines/ocv stockpile 2013/en/
http://dx.doi.org/10.1016/j.ijid.2014.03.570
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Guidance for effective elimination of cholera
epidemics in a sustainable manner in the
Democratic Republic of Congo and other high
risk countries
F. Haaser
Veolia Environment Foundation, Nanterre, France
In a re-emerging context of cholera worldwide, especially in
Africa, a replicable approach has been developed by govern-
mental, non-governmental and international organisations in the
Democratic Republic of Congo, with the support of the Veolia Envi-
ronnement Foundation. The developed methodology integrates
epidemiology studies with water, sanitation and hygiene studies.
It consists in effectively eliminating cholera and other waterborne
diseases by securing and reinforcing access to potable water, effec-
tive sanitation services and hygiene education. A Geographical
Information System is used to combine the results of epidemiology
studies with water, sanitation and hygiene diagnosis, to establish a
scientiﬁcally-based cholera hotspots mapping, and identify at risk
populations in each of the hotspots. In the D.R.C., the epidemi-
ology studies led to the identiﬁcation of 8 “hotspots” of cholera
emergence in the Eastern part of the country, in the Great Lakes
Region, in which preventive actions are being focused. On the long
run, preventive interventions are expected to signiﬁcantly decrease
cholera and other waterborne diseases incidence, by increasing
access to safe water and reducing unsafe water use for instance.
Indeed, more reliable and close water access will encourage bet-
ter hygiene practices in the households, and will help saving time
for women and children generally involved in the water collec-
tion. The impact is consequently expected to be broad: sanitary,
social and economic. The approach goes far beyond the tradi-
tional emergency medical response to cholera epidemics. It is
being implemented in the D.R.C. to change the traditional cholera
responseparadigmfromtreatment toprevention. Basedon the case
study being held in the D.R.C., the Global Alliance Against Cholera
(G.A.A.C. –www.choleraalliance.org) was created in 2010, bringing
together international private and public stakeholders, recognised
as experts in the ﬁelds of Cholera, Health, Water, Sanitation and
Hygiene. The main objective of the Alliance is to advocate for the
sustainable multisectoral approach adopted in the D.R.C., at an
international level and that can serve as a model for other areas
and communities affected by the disease. The G.A.A.C. also works
on strategies tobetter integrate the commonapproach into affected
countries’ national policies, in order to sustainably eliminate this
scourge.
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